Skip to main content

Table 2 Assumed market shares of interventional treatments for varicose veins in Germany*

From: Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system

Market shares

2013

2014

2015

2016

2017

World without ClosureFast (1st and 2nd treatment)

     

Surgery

0.95

0.95

0.95

0.95

0.95

UGFS

0.05

0.05

0.05

0.05

0.05

World with ClosureFast (1st and 2nd treatment)

     

Surgery

0.85

0.80

0.75

0.70

0.65

ClosureFast

0.10

0.15

0.20

0.25

0.30

UGFS

0.05

0.05

0.05

0.05

0.05

  1. * Excluding top-up treatment.